sur Mallia Innovations
Mallia Aesthetics Clears Regulatory Hurdles for sCD83-Based Hair Growth Ingredient
Mallia Aesthetics GmbH has announced significant progress in the regulatory process for its novel hair growth ingredient, MAL-838, derived from the protein sCD83. This advancement positions the company for the forthcoming launch of its 8T3 product line later this year.
The safety of MAL-838 has been affirmed following comprehensive evaluations, ensuring compliance with European Cosmetics Regulation EU 1223/2009. Additionally, MAL-838 has been officially recognized in the European CosIng database with the INCI name sh-Polypeptide-167. This step enhances consumer transparency and product labeling standards.
The 8T3 products have also been certified as microbiome-friendly, offering a gentle alternative in the hair growth market. Mallia aims to deliver effective and skin-compatible solutions, steering away from traditional products containing harsh solvents or preservatives.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Mallia Innovations